DouglasS.ReintgenMD

PubMed

• 7 citations
  Current management of melanoma patients with nodal metastases.
  Dale Han, Alexander C.J. van Akkooi, Richard J. Straker, Adrienne B. Shannon, Giorgos C. Karakousis, Lin Wang, Kevin B. Kim, Douglas S. Reintgen> ;Clinical & Experimental Metastasis. 2021 May 7
• 13 citations
  Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial.
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Annals of Surgery. 2021 Apr 1
• 14 citations
  Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials.
  Mark B. Faries, Dale Han, Michael Reintgen, Lauren Kerivan, Douglas S. Reintgen, Corrado Caracò> ;Clinical & Experimental Metastasis. 2018 May 18
• 2 citations
  Localization Methods for Excisional Biopsy in Women With Nonpalpable Mammographic Abnormalities
  Christine Rodhouse, Iman Soliman, Mariah Cruse, Joseph Kastrenakes, C.J. Augustine, Alexis Ludy, Eric Reintgen, Alexa Hoadley, Divya Desai, Minh Nguyen, Douglas Reintgen> ;Clinical Breast Cancer. 2017 Feb 1
• 36 citations
  Phase III randomized study of 4 weeks of high-dose interferon-α-2b in stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) melanoma: A trial of the Eastern Coop...
  Sanjiv S. Agarwala, Sandra J. Lee, Wai-Ki Yip, Uma N. M. Rao, Ahmad A. Tarhini, Gary I. Cohen, Douglas S. Reintgen, Terry L. Evans, Joanna M. Brell, Mark R. Albertini,...> ;Journal of Clinical Oncology. 2017 Jan 30
• 47 citations
  Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ...
  Kelly M. McMasters, Michael E. Egger, Michael J. Edwards, Merrick I. Ross, Douglas S. Reintgen, R. Dirk Noyes, Robert C.G. Martin, James S. Goydos, Peter D. Beitsch, M...> ;Journal of Clinical Oncology. 2016 Sep 19
• 5 citations
  Extracapsular Extension in the Sentinel Lymph Node: Guidelines for Therapy
  Santosh Swaminathan, Michael Reintgen, Lauren Kerivan, Eric Reintgen, Jeff Smith, Douglas S. Reintgen> ;Clinical Breast Cancer. 2016 Jun 1
• 16 citations
  Breast Lymphatic Mapping and Sentinel Lymph Node Biopsy: State of the Art: 2015
  Michael Reintgen, Lauren Kerivan, Eric Reintgen, Santosh Swaninathan, Douglas S. Reintgen> ;Clinical Breast Cancer. 2016 Jun 1
• 32 citations
  Comparison of Sentinel Lymph Node Micrometastatic Tumor Burden Measurements in Melanoma
  Michael E. Egger, Matthew R. Bower, Irene A. Czyszczon, Hanan Farghaly, R. Dirk Noyes, Douglas S. Reintgen, Robert C.G. Martin, Charles R. Scoggins, Arnold J. Stromber...> ;Journal of the American College of Surgeons. 2014 Apr 1
• 23 citations
  Evidence for a Better Nodal Staging System for Melanoma: The Clinical Relevance of Metastatic Disease Confined to the Sentinel Lymph Nodes
  Michael Reintgen, Lauren Murray, Kurt Akman, Rosemary Giuliano, Alyson Lozicki, Steve Shivers, Douglas S. Reintgen> ;Annals of Surgical Oncology. 2013 Feb 1
• 11 citations
  Breast Preservation in Women With Giant Juvenile Fibroadenoma
  Dana Matz, Lauren Kerivan, Michael Reintgen, Kurt Akman, Alyson Lozicki, Tully Causey, Corinne Clynes, Rosemary Giuliano, Geza Acs, John M. Cox, Charles E. Cox, Dougla...> ;Clinical Breast Cancer. 2013 Jun 1
• 21 citations
  Diversity of Stage III Melanoma in the Era of Sentinel Lymph Node Biopsy
  Michael E. Egger, Glenda G. Callender, Kelly M. McMasters, Merrick I. Ross, Robert C.G. Martin, Michael J. Edwards, Marshall M. Urist, R. Dirk Noyes, Jeffrey J. Sussma...> ;Annals of Surgical Oncology. 2013 Mar 1
• 19 citations
  A phase 2 study of tasisulam sodium (LY573636 sodium) as second‐line treatment for patients with unresectable or metastatic melanoma
  John M. Kirkwood, Rene Gonzalez, Douglas S. Reintgen, Philip Clingan, Robert R. McWilliams, Dinesh P. de Alwis, Annamaria Zimmermann, Michael P. Brown, Robert Ilaria, ...> ;Cancer. 2011 Oct 15
• 132 citations
  Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I)
  J. Harrison Howard, John F. Thompson, Nicola Mozzillo, Omgo E. Nieweg, Harald J. Hoekstra, Daniel F. Roses, Vernon K. Sondak, Douglas S. Reintgen, Mohammed Kashani-Sab...> ;Annals of Surgical Oncology. 2012 May 31
• 1 citations
  Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
  John V Kiluk, Quan P Ly, Tammi Meade, Daniel Ramos, Douglas S Reintgen, Sophie Dessureault, Michelle Davis, Corinne Shamehdi, Charles E Cox> ;Annals of Surgical Oncology. 2011 Dec 1
• 6 citations
  Pleomorphic lobular carcinoma in situ: treatment options for a new pathologic entity.
  Lauren Murray, Michael Reintgen, Kurt Akman, Charles E. Cox, John M. Cox, Douglas S. Reintgen, Harvey Greenberg, Verne Vrcel> ;Clinical Breast Cancer. 2012 Feb 1
• 192 citations
  Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.
  Armando E. Giuliano, Debra Hawes, Karla V. Ballman, Pat Whitworth, Peter W. Blumencranz, Douglas S. Reintgen, Monica Morrow, A. Marilyn Leitch, Kelly K. Hunt, Linda M....> ;JAMA. 2011 Jul 27
• 601 citations
  gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
  Douglas J. Schwartzentruber, David H. Lawson, Jon M. Richards, Robert M. Conry, Donald M. Miller, Jonathan S. Treisman, Fawaz Gailani, Lee B. Riley, Kevin C. Conlon, B...> ;The New England Journal of Medicine. 2011 Jun 2
• 27 citations
  The Prognostic Significance of Nonsentinel Lymph Node Metastasis in Melanoma
  Russell E. Brown, Merrick I. Ross, Michael J. Edwards, R. Dirk Noyes, Douglas S. Reintgen, Lee Hagendoorn, Arnold J. Stromberg, Robert C.G. Martin, Kelly M. McMasters,...> ;Annals of Surgical Oncology. 2010 Jul 20
• 142 citations
  The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)
  Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert Elashoff, Edwin C. Glass, Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, Harold J. Hoekstra, Constanti...> ;Annals of Surgical Oncology. 2010 Jul 8
• 67 citations
  Prognostic Information From Sentinel Lymph Node Biopsy in Patients With Thick Melanoma
  Charles R. Scoggins, Adrianne L. Bowen, Robert C.G. Martin, Michael J. Edwards, Douglas S. Reintgen, Merrick I. Ross, Marshall M. Urist, Arnold J. Stromberg, Lee Hagen...> ;Archives of Surgery. 2010 Jul 1
• 33 citations
  Second primary melanomas: incidence and outcome.
  Matthew Bower, Charles R. Scoggins, Robert C.G. Martin, Michael P. Mays, Michael J. Edwards, Douglas S. Reintgen, Merrick I. Ross, Marshall M. Urist, R. Dirk Noyes, Je...> ;The American Surgeon. 2010 Jul 1
• 10 citations
  Advances in local-regional treatment for patients with early-stage breast cancer: a review of the field.
  Christian Reintgen, Douglas S. Reintgen, Lawrence J. Solin> ;Clinical Breast Cancer. 2010 Jun 1
• 8 citations
  The changing face of malignant melanoma.
  Christian Reintgen, Steven Shivers, Michael Reintgen, Rosemary Giuliano, Douglas S. Reintgen> ;Journal of Surgical Oncology. 2010 May 1
• 13 citations
  Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: A Review From ACOSOG Z0010
  Lee G. Wilke, Karla V. Ballman, Linda M. McCall, Armando E. Giuliano, Pat Whitworth, Peter W. Blumencranz, Douglas S. Reintgen, William E. Burak, A. Marilyn Leitch, Ke...> ;Annals of Surgical Oncology. 2010 Mar 23
• Join now to see all